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New & Noteworthy: Small airway hyperresponsiveness is demonstrated in 28 
precision-cut lung slices from guinea pigs with COPD-like changes induced by 29 
chronic lipopolysaccharide exposure and from patients with mild to moderate COPD. 30 
In both species, the hyperresponsiveness is not caused by increased airway smooth 31 
muscle mass, but may involve parenchymal destruction as well as passive 32 
biomechanical changes in the airway wall.  33 
 34 
Keywords: airway constriction, airway remodeling, biomechanical modeling, 35 
emphysema, human lung 36 
 37 





The direct relationship between pulmonary structural changes and airway 39 
hyperresponsiveness (AHR) in chronic obstructive pulmonary disease (COPD) is 40 
unclear. We investigated AHR in relation to airway and parenchymal structural 41 
changes in a guinea pig model of COPD and in COPD patients. 42 
Precision-cut lung slices (PCLS) were prepared from guinea pigs challenged 43 
with lipopolysaccharide or saline twice weekly for twelve weeks. Peripheral PCLS 44 
were obtained from patients with mild to moderate COPD and non-COPD controls. 45 
AHR to methacholine was measured in large and small airways using video-assisted 46 
microscopy. Airway smooth muscle mass and alveolar airspace size were determined 47 
in the same slices. A mathematical model was used to identify potential changes in 48 
biomechanical properties underlying AHR. 49 
In guinea pigs, lipopolysaccharide increased the sensitivity of large (>150μm) 50 
airways towards methacholine by 4.4-fold and the maximal constriction of small 51 
airways (<150μm) by 1.5-fold. Similarly, increased small airway responsiveness was 52 
found in COPD patients. In both lipopolysaccharide-challenged guinea pigs and 53 
patients, airway smooth muscle mass was unaltered, whereas increased alveolar 54 
airspace correlated with small airway hyperresponsiveness in guinea pigs. Fitting the 55 
parameters of the model indicated that COPD weakens matrix mechanical properties 56 
and enhances stiffness differences between the airway and the parenchyma, in both 57 
species.  58 
In conclusion, this study demonstrates small airway hyperresponsiveness in 59 
PCLS from COPD patients. These changes may be related to reduced parenchymal 60 
retraction forces as well as biomechanical changes in the airway wall. PCLS from 61 
lipopolysaccharide-exposed guinea pigs may be useful to study mechanisms of small 62 
airway hyperresponsiveness in COPD. 63 





Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease, 65 
characterized by a progressive and partially irreversible decline in lung function and 66 
by airway hyperresponsiveness (AHR) (13, 14, 23, 24). Chronic inflammation in 67 
COPD causes structural alterations and narrowing of particularly the small airways, 68 
and emphysema, characterized by parenchymal destruction. It has been proposed 69 
that loss of lung function and AHR may result from small airway remodeling - 70 
including increased airway smooth muscle (ASM) mass - and from loss of elastic 71 
recoil by parenchymal damage (13, 14, 23, 24). These structural changes may differ 72 
between patients, depending on various factors (13).  73 
Although this hypothesis has been around for several decades, evidence for a 74 
direct relationship between structural changes in the lung and small airway function is 75 
still lacking. Measurement of airway mechanics in precision-cut lung slices (PCLS) 76 
using video-assisted microscopy ex vivo (19, 26) may be highly instrumental in 77 
investigating the impact of structural changes on airway responsiveness. Microscopic 78 
visualization allows to perform these studies even in the smallest airways, a major 79 
breakthrough for the study of small airway function. 80 
Limited studies on small airway mechanics in PCLS from animal models of 81 
COPD are known (5, 7, 8, 16, 17, 33). In one of these studies, enhanced small 82 
airway responsiveness to carbachol and serotonin was found in rats after chronic in 83 
vivo exposure to tobacco smoke, which was associated with increased airway wall α-84 
smooth muscle actin (α-SMA) content (5). In contrast, no small airway 85 
hyperresponsiveness was observed in mice after short-term exposure to cigarette 86 
smoke (8), elastase (17) or lipopolysaccharide (LPS) (7). However, exposure of 87 
mouse PCLS to elastase or collagenase ex vivo induced AHR to acetylcholine and 88 




methacholine (16, 17, 33). Mechanical studies in PCLS from patients with COPD 89 
have thus far not been described.  90 
In this study, we investigated alterations in the responsiveness of large and 91 
small intrapulmonary airways to methacholine in PCLS obtained from a guinea pig 92 
model of COPD induced by chronic LPS exposure (22). This model resembles COPD 93 
patho(physio)logy in several ways: the presence of neutrophilic inflammation, mucus 94 
hypersecretion, emphysema, small airway fibrosis and vascular remodeling (22). In 95 
addition, guinea pig lungs contain both large and small airways. We also determined 96 
the relationship between structural components of the airways and parenchyma 97 
(ASM mass and parenchymal integrity) and responsiveness of the individual airways 98 
within the same PCLS. Importantly, this relationship was also assessed for small 99 
airways in lung slices obtained from human control subjects and patients with mild to 100 
moderate COPD. Finally, we used a multiscale model of an airway embedded in 101 
parenchyma (12) to identify possible alterations in biomechanical properties that 102 





Outbred, male, specified pathogen-free Dunkin Hartley guinea pigs (Harlan, 108 
Heathfield, UK) weighing 350–400 g were used. The animals were housed in pairs 109 
under a 12 hour light/dark cycle in a temperature- and humidity-controlled room with 110 
food and tap water ad libitum. All animal care and experimental procedures complied 111 
with the animal protection and welfare guidelines and were approved by the 112 
Institutional Animal Care and Use Committee of the University of Groningen, The 113 
Netherlands, and are reported in compliance with the ARRIVE guidelines (18). 114 




Lipopolysaccharide instillation 115 
At the start of the protocol, guinea pigs were randomly selected to be challenged by 116 
intranasal instillation of 200 μL lipopolysaccharide (LPS, Sigma-Aldrich, St. Louis, 117 
MO, USA, 5 mg/mL in sterile saline) or 200 μL sterile saline (control group) twice 118 
weekly for 12 consecutive weeks as described by Pera et al. (22). To this aim, 119 
conscious guinea pigs were held in an upright position, while the LPS solution was 120 
slowly instilled. After the intranasally instilled solution was aspirated, the animals 121 
were kept in the upright position for an additional 2 min to allow sufficient spreading 122 
of the fluid throughout the airways. Animal welfare was monitored by weighing the 123 
animals prior to each intranasal instillation; no animals needed to be withdrawn from 124 
the protocol. Previous studies have demonstrated that guinea pigs challenged with 125 
LPS are a good model for COPD as it induces various inflammatory and pathological 126 
changes closely mimicking COPD (22, 32). 127 
 128 
Guinea pig lung slices 129 
24 h after the last challenge, precision-cut lung slices were prepared as described 130 
previously (20, 25). The animals were sacrificed using an overdose of pentobarbital 131 
(Euthasol 20%, Produlab Pharma, Raamsdonkveer, The Netherlands) followed by 132 
exsanguination via the aorta abdominalis. The trachea was cannulated, the 133 
diaphragm was opened and the lungs were filled through the cannula at constant 134 
pressure with a low melting-point agarose (Gerbu Biotechnik GmbH, Weiblingen, 135 
Germany) solution (1.5%) in a buffer containing 0.9 mM CaCl2, 0.4 mM MgSO4, 2.7 136 
mM KCl, 58.2 mM NaCl, 0.6 mM NaH2PO4, 8.4 mM glucose. 13 mM NaHCO3, 12.6 137 
mM Hepes, 0.5 mM sodium pyruvate, 1 mM glutamine, MEM-amino acids mixture 138 
(1:50), and MEM-vitamins mixture (1:100), pH = 7.2. The agarose solution contained 139 
1 μM isoproterenol to prevent post-mortem constriction (25). After filling, the lungs 140 




were covered with ice for at least 30 min, in order to solidify the agarose for slicing. 141 
The lungs were removed and cylindrical tissue cores were prepared from the lobes 142 
using a rotating sharpened metal tube (diameter 15 mm), followed by slicing the 143 
tissue in ice cold buffer composed of 1.8 mM CaCl2, 0.8 mM MgSO4, 5.4 mM KCl, 144 
116.4 mM NaCl, 1.2 mM NaH2PO4, 16.7 mM glucose, 26.1 mM NaHCO3, 25.2 mM 145 
Hepes, and 1 μM isoproterenol, pH =7.2, using a tissue slicer (CompresstomeTM VF- 146 
300 microtome, Precisionary Instruments, San Jose CA, USA). Lung slices were cut 147 
at a thickness of 500 μm and washed several times to remove the agarose and cell 148 
debris from the tissue. Slices were incubated in a 12-wells plate overnight in minimal 149 
essential medium composed of 1.8 mM CaCl2, 0.8 mM MgSO4, 5.4 mM KCl, 116.4 150 
NaCl, 1.2 mM NaH2PO4, 16.7 mM glucose, 26.1 mM NaHCO3, 25.2 mM Hepes, 0.5 151 
mM sodium pyruvate, 1 mM glutamine, MEM-amino acids mixture (1:50), and MEM-152 
vitamins mixture (1:100), pH = 7.2, containing penicillin and streptomycin (1:100), at 153 
37oC in a CO2- and humidity-controlled atmosphere. 154 
 155 
Human lung slices 156 
Peripheral lung tissue from COPD GOLD 1 (n=4) and GOLD 2 (n=3) patients and 157 
from non-COPD control subjects (n=5) was obtained from subjects undergoing 158 
surgery for lung cancer using tumor-free tissue far from the tumor site, except one 159 
control that was obtained from a non-transplanted donor lung. All tissue was 160 
collected according to the Research Code of the University Medical Center 161 
Groningen 162 
(https://www.umcg.nl/SiteCollectionDocuments/English/Researchcode/UMCG-163 
Researchcode,%20basic%20principles%202013.pdf) and national ethical and 164 
professional guidelines (‘Code of conduct’, Dutch federation of biomedical scientific 165 
societies, http://www.federa.org). Characteristics of the subjects are shown in Table 1 166 




of the printed version. After placing on a metal plate on ice, 2% low-melting agarose 167 
was slowly injected into the tissue, evenly distributed at several sites of the tissue, 168 
essentially as described by Sturton et al. (28). Subsequently, the tissue was covered 169 
with ice for 15 min. Cylindrical cores of 15 mm in diameter were prepared, cut with a 170 
tissue slicer into 500 μm thin slices, and processed as described above for guinea pig 171 
lung slices. 172 
 173 
Airway responsiveness measurements 174 
After washing the slices in medium airway responsiveness to methacholine (10-9 - 175 
3.10-3 M, using cumulative concentrations in half-log increments) was assessed in 1- 176 
6 slices per animal or human donor, using video-assisted microscopy (Nikon Eclipse 177 
TS 100). To this aim individual slices were positioned under the microscope using a 178 
24-wells plate, mechanically maintained with a Teflon ring of 7 mm inner diameter 179 
and 10 mm outer diameter, and covered with 1 mL of minimal essential medium. 180 
Only slices were used with approximately circular airways (longest/shortest 181 
diameter<2) and with ciliary beating as an indication of intact epithelium and viability 182 
of the slices. In guinea pig slices methacholine-induced contraction was measured 183 
both in large and small airways (in this species defined by diameters larger and 184 
smaller than 150 µm, respectively), whereas in human slices only small airways (< 185 
500 µm) were studied. To quantify airway luminal area, image acquisition software 186 
(NIS-Elements, Nikon) was used. Images of the airways were acquired every 2 sec 187 
during the whole course of the experiment, starting 2 min before the addition of the 188 
first dose of contracting agent to allow for baseline measurements of the airway 189 
caliber. Airway constriction was then expressed as percentage of the initial (baseline) 190 
area of the airway lumen. Per slice, one airway was measured. After establishing the 191 




cumulative concentration-response curve, slices were thoroughly washed in fresh 192 
medium.  193 
 194 
Histochemistry  195 
After a subsequent overnight washout, lung slices were placed in cassettes 196 
supported by biopsy foam pads, fixed in 10% formalin for 24 h, and embedded in 197 
paraffin. Paraffin sections (4 μm thin) were cut from the slices to assess remodeling 198 
parameters. Airway smooth muscle mass was determined by α-SMA staining. After 199 
deparaffinization, endogenous peroxidase was blocked for 30 min using 0.3% H202 in 200 
phosphate buffered saline (PBS; 140 mM NaCl, 2.6 mM KCl, 1.4 mM KH2PO4, 8.1 201 
mM Na2HPO4, pH7.4). After 5 minutes washing with PBS, the sections were cooked 202 
in 10 mM Na3-citrate buffer, pH 6, for 5 min using a pressure cooker. Sections were 203 
then incubated for 15 min with 1% triton-x100 in PBS, and washed three times with 204 
PBS afterwards. The sections were incubated for two min with mouse anti-α-smooth 205 
muscle actin antibody (Sigma-Aldrich, St. Louis, MO, USA), diluted 1:1000 in 1% 206 
bovine serum albumin (BSA) in PBS. Subsequently, the sections were incubated for 207 
30 min with 1% BSA in PBS and washed three times with PBS. The secondary 208 
antibody (horse radish peroxidase-conjugated goat anti-mouse IgG antibody (Sigma-209 
Aldrich, St. Louis, MO, USA), 1:200 in 1 % BSA in PBS) was incubated for 30 min 210 
and washed three times with PBS. 3,3'-diaminobenzidine (DAB) was dissolved in 211 
PBS at a concentration of 0.34 mg/ mL and 0.3% H2O2 was added just before use. 212 
After 20 min incubation, sections were washed with ultra-pure water and 213 
counterstained with haematoxylin. After 5 min rinsing under running tap water, 214 
sections were dehydrated in ethanol and covered with mounting medium. Airways 215 
were digitally photographed and analyzed using Image J software (National Institutes 216 
of Health, Bethesda, MD). The positively stained area (μm2) was normalized to the 217 




square of the basement membrane length (μm2). For evaluation of emphysema, 218 
paraffin sections were stained with haematoxylin and eosin. Mean linear intercept 219 
(MLI) was determined as a measure of alveolar airspace size as described previously 220 
(21), using 20 to 25 photomicroscopic images (magnification 200x) per slice. 221 
 222 
Mathematical model 223 
A multiscale biomechanical model previously developed (12) was used to couple 224 
contractile force generated by airway smooth muscle at the cell level and the 225 
narrowing of a non-linearly elastic airway wall embedded in parenchyma. Briefly, this 226 
model considers the airway as an axisymmetric thick-walled cylinder of fixed length in 227 
a plane-strain approximation (with no axial displacement) and consists of two layers 228 
representing the airway wall and the surrounding parenchymal tissue. The 229 
parenchyma is assumed to be a compressible linear elastic material with 230 
compressibility ν, which can be reduced to mimic connective tissue damage 231 
associated with COPD. The airway wall is considered to be an incompressible 232 
nonlinear elastic material of modulus represented by the variable γ when 233 
parametrized relative to the elastic modulus of the parenchyma at zero stress. As 234 
such, an increase in γ may be interpreted as an increase of airway elasticity 235 
modulated by matrix structure, and/or a degradation of elastin in the parenchyma. 236 
The finite thickness χ of the airway wall is normalized by the radius of the lumen. 237 
Fibers embedded as rings in the airway wall represent the ASM bundles and the 238 
collagen-dominated ECM; they are thus assumed to passively stiffen as collagen is 239 
recruited upon airway inflation (uncrimping of collagen fibers and thus increased 240 
load-bearing) and to actively generate a contractile force upon ASM activation. The 241 
passive stiffness of these fibers is governed by two parameters C1 and C2: C1 takes 242 
into account the density of fibers whereas C2 governs the nonlinear increase in the 243 




stiffness of the fibers as they stretch. The active contribution of the ASM in the 244 
mechanical properties of the airway results from cellular forces generated by 245 
contractile units made of a myosin filament and adjacent actin filaments. β is a 246 
parameter accounting for the volume fraction of the ASM cells in the airway, the 247 
number of parallel myosin filaments within a single ASM cell and also indirectly for 248 
the density of receptors within an ASM cell. Multiplying β by the contractile force 249 
generated by a single myosin filament determined via the Huxley-Hai-Murphy (HHM) 250 
model, results in the overall contractile force of the ASM. Note that a fixed pre-stress 251 
is also applied to mimic the inflation of the lung in the preparation of the PCLS. 252 
Additionally, displacement and radial stress are assumed to be always continuous at 253 
the boundary between the airway wall and the parenchyma.  254 
First, simulations using this model were used to generate concentration-255 
response curves and identify a baseline set of parameters fitting the concentration-256 
response curves from the human and guinea pig control data. Further simulations 257 
were then carried out to determine the changes required in the 6 parameters above 258 
to generate similar changes to those observed in the dose-response curves of human 259 
COPD and LPS challenged guinea pig PCLS. The parameter changes identified in 260 
this way enable inference of the structural changes that could have occurred to 261 
generate the observations. The MATLAB scripts for running model simulations as 262 
described here can be obtained by contacting the corresponding author of Hiorns et 263 
al, 2014 (12). 264 
  265 
Data analysis 266 
Data are expressed as means±SEM. An n=1 represents the average of the 267 
measurements of each airway classification per animal. A power analysis (mu1-268 
mu2=40, sigma=30, alpha=0.5, power=0.8) determined that 9 animals were to be 269 




included per group for the constriction experiments. Per group, 10 animals were 270 
included to anticipate an experimental dropout rate of 10% and which allowed for 271 
housing all guinea pigs in pairs. Statistical differences were determined by two-way 272 
ANOVA, by paired or unpaired Student’s t-test or by Mann-Whitney U test as 273 
appropriate. Correlations were determined using Pearson’s correlation coefficient 274 




Airway responsiveness in guinea pigs  279 
Methacholine induced a concentration-dependent constriction of intrapulmonary large 280 
and small airways in PCLS obtained from saline- and LPS-challenged guinea pigs 281 
(Fig 1A and 1B). Interestingly, the maximal constriction (Emax) of the large airways 282 
from the saline-challenged controls was 1.8-fold higher compared to that of small 283 
airways of the same animals (P < 0.001), without a difference in sensitivity (pD2) 284 
towards methacholine (Table 2). In the large airways of PCLS from LPS-challenged 285 
animals, a 4.4-fold higher sensitivity towards methacholine was observed compared 286 
to large airways from saline-challenged controls (P < 0.01), with a small increase in 287 
maximal effect (P < 0.05, Fig. 1A, Table 2). The maximal constriction of small airways 288 
from LPS-challenged animals was 1.5-fold higher as compared to saline-challenged 289 
controls (P < 0.001), without a difference in sensitivity towards methacholine (Fig. 1B, 290 
Table 2). Airway sizes among saline- and LPS-challenged guinea pigs, respectively, 291 
were similar for large (265±16 µm vs 264±15 µm) and small (112±5 µm vs 111±4 292 
µm). 293 
  294 




ASM mass and alveolar airspace size in guinea pigs  295 
Compared to saline-challenged controls, repeated LPS challenge did not alter ASM 296 
mass of either large or small airways as determined by α-SMA-positive area (Fig. 297 
2A). Consequently, no correlations between Emax or pD2 and ASM mass were 298 
observed (Fig. 2B).  299 
Repeated LPS challenge did induce a trend towards an increase in MLI as 300 
compared to saline-challenged animals (P < 0.10, Fig. 2C). Interestingly, a significant 301 
correlation between MLI and Emax of small, but not large, airways was found (Fig. 302 
2D). No correlations between MLI and pD2-values were observed (Fig. 2D). 303 
 304 
Small airway responsiveness in human PCLS 305 
The responsiveness of human peripheral control airways to methacholine (Fig. 3, 306 
Table 2) was similar to that in the small airways from saline-challenged guinea pigs 307 
(Fig. 1B, Table 2). A 1.5-fold higher maximal constriction (P < 0.05) was observed in 308 
lung slices obtained from patients with COPD as compared to control subjects, 309 
without a difference in pD2 (Fig. 3, Table 2). There was no difference between the 310 
airway diameters of control subjects (273±59 μm) and COPD patients (227±48 μm). 311 
Remarkably, the hyperresponsiveness of the COPD airways was identical to that 312 
observed in the small airways of the LPS-challenged guinea pigs.  313 
 314 
ASM mass and alveolar airspace size in human PCLS 315 
No difference in ASM mass was found between slices from control subjects and 316 
subjects with COPD (Fig. 4A). A 1.2-fold higher MLI was measured in the lung slices 317 
of the COPD patients as compared to the control subjects (P < 0.05, Fig. 4C). There 318 
were no significant correlations between the α-SMA-positive area (Fig. 4B) or the MLI 319 
(Fig. 4D) and the Emax/pD2 of methacholine-induced airway constriction.  320 





Changes in biomechanical properties in PCLS from COPD patients and LPS-322 
challenged guinea pigs 323 
In the model, the biomechanical properties of the airway wall (ASM and collagen 324 
fibers) and parenchyma are characterized by the parameters listed in Figure 5A and 325 
Table 3 (12). Any structural changes in the airway or parenchyma would modify these 326 
parameters, and impact the mechanical response to agonist challenge. Baseline 327 
values of these parameters were first obtained by fitting a simulated concentration-328 
contraction curve to the experimental concentration-contraction one from human 329 
control subjects (Fig. 5B, Table 3). The effect of changing one parameter at a time 330 
was then explored. Similar baseline airway diameters and ASM mass measured 331 
between control and COPD slices justified keeping the airway wall thickness (χ) and 332 
ASM density and/or muscarinic receptor density (β) at baseline values for all human 333 
data simulations. Simulating reduction in collagen fibers density within the airway wall 334 
(C1) or in the extent to which they are recruited (C2) generated minimal 335 
hyperresponsiveness (Fig. 5B). Similarly, reducing the compressibility (ν) or the 336 
stiffness (increased γ) of the parenchyma relative to the airway wall generated small 337 
levels of hyperresponsiveness (Fig. 5B). Mimicking structural changes to the collagen 338 
matrix within the airway wall without changes to the parenchyma, and vice versa, had 339 
thus a limited impact. In contrast, all these parametric changes implemented 340 
simultaneously induced a significant shift in the simulated dose-response curve, 341 
which matched the experimental data obtained on COPD slices (Fig. 5B; Table 3). 342 
This suggests that structural changes to the matrix occurring in COPD (2) affect both 343 
the airway wall and the parenchyma, modifying the effective mechanical properties of 344 
both compartments.  345 




 For guinea pig slices, model baseline parameters were first fitted to the saline-346 
challenged concentration-response curve for small airways (Fig. 5C, Table 3). Higher 347 
ASM/muscarinic receptor density (β) and non-zero inflation pressure were required to 348 
fit the guinea pig data. Changes in both airway wall and parenchymal properties were 349 
needed to match the LPS-challenged guinea pig experimental concentration-350 
response curve for small airways. Specifically, a slightly thicker airway was needed 351 
(parameter set 1 or 2), together with reduced collagen fiber density and parenchymal 352 
compressibility and stiffness relative to the baseline guinea pig parameters (Fig. 5C, 353 
Table 3). In the case of the saline-treated guinea pig data for large airways, simulated 354 
dose-response curves fitted to the experimental dose-response curve (Fig. 5D, Table 355 
3) suggested that slightly thicker airways (χ) as well as significantly increased 356 
ASM/muscarinic receptor density (β) are present. The biomechanical model was 357 
unable to generate dose-response curves for the LPS-treated guinea pig data for the 358 
large airways.  359 
 360 
DISCUSSION 361 
This study successfully shows the high potential of guinea pig and human PCLS in 362 
studying (small) airway mechanics in relation to tissue remodeling in COPD. Both in 363 
PCLS from a guinea pig model of LPS-induced COPD and in PCLS from patients 364 
with mild to moderate COPD we demonstrated small airway hyperresponsiveness to 365 
methacholine, which is not caused by increased ASM mass, but may be related to 366 
reduced parenchymal stiffness and compressibility involving increased alveolar 367 
airspace size and reduced stiffness of the passive components of the airway wall.  368 
In PCLS from LPS-challenged guinea pigs, a 1.5-fold increase in maximal 369 
methacholine-induced airway constriction was observed in the small airways, without 370 
a change in sensitivity towards the agonist. Only a small increase in Emax was 371 




observed in the large airways of LPS-challenged animals, due to the pronounced 372 
(90%) methacholine-induced constriction of these airways in the saline group. An 373 
increase in pD2 was observed in large airways. Further studies indicated that 374 
emphysema may be involved in LPS-induced small airway hyperresponsiveness, as 375 
increased alveolar airspace sizes were positively correlated with the Emax in small 376 
airways within the same PCLS. No correlation between these parameters was found 377 
for the large airways; neither was there a correlation between MLI and pD2 values for 378 
either airway type. From a pharmacological point of view, these results indicate that 379 
post-receptor changes are involved in the increased small airway constriction to 380 
methacholine, which may at least partially be caused by structural changes in the 381 
parenchyma. Since ASM mass was unaltered after LPS challenge for either airway 382 
type and there was no correlation between ASM mass and airway responsiveness, 383 
ASM mass per se is not an important determinant of AHR in this model.  384 
Remarkably, we found a larger maximal methacholine-induced narrowing of 385 
the large airways as compared to the small airways, both after saline and LPS 386 
challenge. Studies in rat PCLS demonstrated that airway responsiveness (reduction 387 
in airway luminal area) towards electrical field stimulation is greater in large airways 388 
compared to small airways (28), whereas no differences in the responsiveness to 389 
methacholine were observed (19). We did not observe significant differences in 390 
sensitivity (pD2) towards methacholine between large and small airways in PCLS 391 
obtained from saline-challenged guinea pigs. However, in rats the sensitivity to 392 
methacholine is greater in the large airways than in the small airways (19), whereas 393 
the opposite has been observed in mice (6). Since different techniques were used in 394 
the latter study (6) to determine the constriction of trachea (contractility) and small 395 
airways (airway area), the responsiveness (Emax) of large and small airways cannot 396 
be compared. The increased responsiveness of the large airways in guinea pig PCLS 397 




is not related to the ASM mass, since – similar to human airways (9) - the relative 398 
ASM thickness was smaller in the large airways. Previous findings using the same 399 
animal model demonstrated that repeated LPS challenge did not alter the active 400 
tension of isolated airways induced by either methacholine or histamine (Pera et al, 401 
unpublished observations) further supporting the contribution of structural changes in 402 
the parenchyma to the observed LPS-induced AHR.  403 
This study also describes the first measurements of airway mechanics in 404 
PCLS from COPD patients. Remarkably, PCLS of human control subjects 405 
demonstrated a similar responsiveness of the peripheral airways to methacholine as 406 
the small airways of saline-challenged guinea pigs. This confirms previous 407 
observations that guinea pig PCLS are an excellent physiological and 408 
pharmacological model for human tissue (25, 27). Similar to the guinea pig data, 409 
hyperresponsiveness to methacholine – characterized by an increased Emax - of 410 
peripheral airways from patients with mild to moderate COPD (GOLD 1 and 2) was 411 
observed. In line with previous studies (13) and the guinea pig model, no changes in 412 
ASM mass in the small airways were observed in patients with mild to moderate 413 
COPD. Slices from the COPD patients did reveal a small but significantly enhanced 414 
MLI, however, no significant correlation between MLI and Emax was observed. This 415 
may be due to both the low number of subjects and the involvement of additional 416 
factors, such as microstructural changes in the extracellular matrix components, 417 
which may similarly impact the mechanical behavior of the airways and the 418 
parenchyma (2).  419 
In the alveolar and small airway walls of COPD patients reduced expression of 420 
elastin and decorin, a proteoglycan involved in the assembly of collagen fibers, and 421 
increased expression of collagen have been described (2, 11, 14, 34, 36). Similar 422 
observations have been reported for smoke- and LPS-induced guinea pig models of 423 




COPD characterized by small airway remodeling and emphysema (4, 15, 23). As the 424 
mechanical properties of collagen fibers highly depend on the quality of their 425 
assembly, higher collagen content does not necessarily lead to a stiffer tissue (30). 426 
Thus, loss of decorin as observed in COPD (14, 34, 36) will lead to disorganization 427 
and sliding of collagen fibers despite an increase of the matrix protein. Indeed, 428 
imaging revealed structural differences of parenchymal collagen and elastin between 429 
non-diseased subjects and COPD patients (1, 31). Moreover, PCLS studies in mice 430 
showed disorganized and stretched parenchymal collagen fibers upon elastin 431 
degradation (33). Consequences of extracellular matrix changes for mechanical 432 
functions of the lung have been explored in PCLS ex vivo and revealed that airway 433 
responsiveness is enhanced upon protease-induced degradation of elastin or 434 
collagen fibers (16, 33).  435 
The emerging hypothesis of a central role of extracellular matrix remodeling in 436 
AHR (2, 3, 30) is further supported by a biomechanical model (12). The contribution 437 
on airway responsiveness of the active ASM cells and the passive airway and 438 
parenchymal matrices could be assessed separately by parametric changes.  439 
Simulations of the contraction experiments could fit the COPD experimental data only 440 
when changes to passive mechanical properties occurred in both the airway wall and 441 
the parenchyma as compared to control PCLS. The relative weakening of the 442 
extracellular matrix in COPD suggested by these changes, potentially including 443 
elastin degradation, decorin loss and disorganization of collagen fibers, is consistent 444 
with both the observation of hyperresponsiveness despite a conserved airway 445 
smooth muscle mass and with the increased MLI in COPD patients and LPS-446 
challenged guinea pigs.  447 
Guinea pig has a thicker ASM layer in comparison to most species, which 448 
could explain why the biomechanical model could not generate concentration-449 




contraction curves for the LPS-treated guinea pig data for the large airways and 450 
would potentially require distinct baseline characteristics. Indeed, the model 451 
parameter fit suggests that in the control data both airway wall thickness and ASM 452 
density needed to be greater than the corresponding human parameters (Table 3). 453 
Another explanation for the failure of the model to simulate the LPS-treated guinea 454 
pig data for the large airways, is a potentially higher baseline tone which the model is 455 
not able to account for. Additionally, any stretch dependent changes in the 456 
parameters (such as decreased tethering in response to strong contraction as a 457 
result of LPS-modified ECM) are not accounted for in the current model, but could be 458 
an explanation for the strong dose response.  459 
Only few studies reported on small airway structure and responsiveness in 460 
PCLS in animal models with characteristics of COPD. Thus, cigarette smoke 461 
exposure of rats during 8-16 weeks increased the sensitivity but not the Emax of 462 
intrapulmonary airways to carbachol and serotonin, and increased ASM mass, which 463 
correlated with the sensitivity to serotonin, but not carbachol (5). Although we did not 464 
find an increased ASM mass in our model or in our patients with mild to moderate 465 
COPD, the absence of a correlation between ASM mass and hyperresponsiveness to 466 
the muscarinic agonist (5) corresponds to our observations. No changes in sensitivity 467 
to serotonin or methacholine were found after acute exposure of the rats to cigarette 468 
smoke (5), in line with a recent study on acute cigarette smoke exposure in mice 469 
(17). In the latter study, a change in the contraction pattern to serotonin, but not to 470 
methacholine, was observed that was associated with a change in ryanodine 471 
receptor expression (8). Although the acute models were characterized by cigarette 472 
smoke-induced inflammation, they are highly unlikely to demonstrate small airway 473 
remodeling and emphysema that are important for AHR in COPD. Similarly, airway 474 
hyperresponsiveness was not induced in PCLS following acute exposure of mice to 475 




LPS, a pro-inflammatory contaminant from gram-negative bacteria in organic dusts 476 
and cigarette smoke that has been associated with the development of COPD as well 477 
as with bacterial infection-induced exacerbations of COPD (10, 21, 22). However, 478 
chronic LPS exposure induced COPD-like inflammation, small airway remodeling and 479 
emphysema in mice and guinea pigs (22, 32, 35). The present study indicates that 480 
biomechanical changes involved in small airway hyperresponsiveness in chronically 481 
LPS-exposed guinea pigs translate to small airway hyperresponsiveness in patients 482 
with COPD.  483 
Regarding the 3Rs of the use of animals in biomedical research (18), the 484 
current method of studying airway responsiveness in PCLS represents both 485 
refinement and reduction. Airway responses of small and large airways to (multiple) 486 
experimental drugs can be individually measured in different PCLS from the same 487 
animal, thus lowering the number of animals needed, whereas refinement is achieved 488 
by measuring AHR ex vivo rather than in vivo. Moreover, linking mathematical 489 
modeling with the functional studies may lead to future reduction of animals needed 490 
to predict outcomes. 491 
 492 
In conclusion, this is the first study demonstrating small airway hyperresponsiveness 493 
in PCLS from patients with mild to moderate COPD, which appears not to be caused 494 
by increased airway smooth muscle mass, but rather to be related to reduced 495 
parenchymal retraction forces and reduced passive stiffness of the airway wall. In 496 
addition, we found evidence that PCLS from chronically LPS-exposed guinea pigs 497 
can serve as a useful model to study mechanisms of small airway 498 
hyperresponsiveness in mild and moderate COPD.   499 





We thank Dr. Ramaswamy Krishnan (Department of Emergency Medicine, Beth 501 
Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) for 502 
helpful discussions. 503 
 504 
GRANTS 505 
This study was supported by the Stichting Astma Bestrijding (grant no. 2010-015 to 506 
Harm Maarsingh, Reinoud Gosens, Wim Timens and Herman Meurs), and the 507 
Medical Research Council UK (grant no. MR/M004643/1 to Bindi S. Brook). 508 
 509 
DISCLOSURES 510 
Part of this study was supported by a grant from Novartis UK. 511 
 512 
AUTHOR CONTRIBUTIONS 513 
H.Ma., H.Me., R.G., W.T., C.M.B., and B.S.B. conceived and designed the 514 
experiments; H.Ma., A.B.Z., C.R.S.E., M.S., A.O., C.M.B., and B.S.B. performed the 515 
experiments ; H.Ma., H.Me., A.B.Z., M.S., W.T., C.M.B., and B.S.B. analyzed the 516 
data; H.Ma., H.Me., C.M.B., and B.S.B. drafted the manuscript; all authors read, 517 
critically revised and approved the final manuscript.  518 





1. Abraham T, Hogg J. Extracellular matrix remodeling of lung alveolar walls in 520 
three dimensional space identified using second harmonic generation and 521 
multiphoton excitation fluorescence. J Struct Biol 171: 189-196, 2010. 522 
2. Bidan C, Veldsink AC, Meurs H, Gosens R. Airway and extracellular matrix 523 
mechanics in COPD. Front Physiol 6: 346, 2015. 524 
3. Burgess JK, Mauad T, Tjin G, Karlsson JC, Westergren-Thorsson G. The 525 
extracellular matrix - the under-recognized element in lung disease? J Pathol 526 
240: 397-409, 2016. 527 
4. Churg A, Wang R, Wang X, Onnervik PO, Thim K, Wright JL. Effect of an 528 
MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling 529 
in guinea pigs. Thorax 62: 706-713, 2007. 530 
5.  Cooper PR, Poll CT, Barnes PJ, Sturton RG. Involvement of IL-13 in tobacco 531 
smoke-induced changes in the structure and function of rat intrapulmonary 532 
airways. Am J Respir Cell Mol Biol 43: 220-226, 2010. 533 
6.   Donovan C, Royce SG, Esposito J, Tran J, Ibrahim ZA, Tang ML, Bailey S, 534 
Bourke JE. Differential effects of allergen challenge on large and small airway 535 
reactivity in mice. PLoS One 8:e74101, 2013. 536 
7. Donovan C, Royce SG, Vlahos R, Bourke JE. Lipopolysaccharide does not 537 
alter small airway reactivity in mouse lung slices. PloS One 10: e0122069, 2015. 538 
8. Donovan C, Seow HJ, Royce SG, Bourke JE, Vlahos R. Alteration of airway 539 
reactivity and reduction of ryanodine receptor expression by cigarette smoke in 540 
mice. Am J Respir Cell Mol Biol 53: 471-478, 2015. 541 




9. Ebina M, Yaegashi H, Takahashi T, Motomiya M, Tanemura M. Distribution of 542 
smooth muscles along the bronchial tree. A morphometric study of ordinary 543 
autopsy lungs. Am Rev Repir Dis 141: 1322-1326, 1990. 544 
10. Eduard W, Pearce N, Douwes J. Chronic bronchitis, COPD, and lung function in 545 
farmers: the role of biological agents. Chest 136: 716-725, 2009. 546 
11. Eurlings IM, Dentener MA, Cleutjens JP, Peutz CJ, Rohde GG, Wouters EF, 547 
Reynaert NL. Similar matrix alterations in alveolar and small airway walls of 548 
COPD patients. BMC Pulm Med 14: 90, 2014. 549 
12. Hiorns JE, Jensen OE, Brook BS. Nonlinear compliance modulates dynamic 550 
bronchoconstriction in a multiscale airway model. Biophysic J 107: 3030–3042, 551 
2014. 552 
13.  Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack 553 
RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway 554 
obstruction in chronic obstructive pulmonary disease. New Engl J Med 350: 555 
2645-2653, 2004. 556 
14. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. 557 
Annu Rev Pathol 4: 435-459, 2009. 558 
15.  Johnson FJ, Reynolds LJ, Toward TJ. Elastolytic activity and alveolar epithelial 559 
type-1 cell damage after chronic LPS inhalation: effects of dexamethasone and 560 
rolipram. Toxicol Appl Pharmacol 207: 257-265, 2005. 561 
16. Kahn MA, Ellis R, Inman MD, Bates JHT, Sanderson MJ, Janssen LJ. 562 
Influence of airway wall stiffness and parenchymal tethering on the dynamics of 563 
bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 299: L98-L108, 2010.  564 




17. Kahn MA, Klanpour S, Stämpfli MR, Janssen LJ. Kinetics of in vitro 565 
bronchoconstriction in an elastolytic mouse model of emphysema. Eur Respir J 566 
30: 691-700, 2007. 567 
18.  Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving 568 
bioscience research reporting: the ARRIVE guidelines for reporting animal 569 
research. PLoS Biol 29: e1000412, 2010. 570 
19.  Martin C, Uhlig S, Ullrich V. Videomicroscopy of methacholine-induced 571 
contraction of individual airways in precision-cut lung slices. Eur Respir J 9: 2479-572 
287, 1996. 573 
20. Oenema TA, Maarsingh H, Smit M, Groothuis GM, Meurs H, Gosens R. 574 
Bronchoconstriction Induces TGF-β release and airway remodelling in guinea pig 575 
lung slices. PLoS One 26: 8(6): e65580, 2013. 576 
21. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha 577 
JA. Relationship between bacterial colonisation and the frequency, character, 578 
and severity of COPD exacerbations. Thorax  57: 759-764, 2002. 579 
22. Pera T, Zuidhof A, Valadas J, Smit M, Schoemaker RG, Gosens R, 580 
Maarsingh H, Zaagsma J, Meurs H. Tiotropium inhibits pulmonary inflammation 581 
and remodelling in a guinea pig model of COPD. Eur Respir J 38: 789-796, 2011. 582 
23. Postma DS, Kerstjens HAM. Characteristics of airway hyperresponsiveness in 583 
asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 584 
158: S187-192, 1998. 585 
24. Postma DS, Timens W. Remodeling in asthma and chronic obstructive 586 
pulmonary disease. Proc Am Thorac Soc 3: 434-439, 2006. 587 




25. Ressmeyer AR, Larsson AK, Vollmer E, Dahlèn SE, Uhlig S, Martin C. 588 
Characterisation of guinea pig precision-cut lung slices: comparison with human 589 
tissues. Eur Respir J 28: 603-611, 2006. 590 
26. Sanderson MJ. Exploring lung physiology in health and disease with lung slices. 591 
Pulm Pharmacol Ther 24: 452-465, 2011. 592 
27. Schlepütz M, Rieg AD, Seehase S, Spillner J, Perez-Bouza A, Braunschweig 593 
T, Schroeder T, Bernau M, Lambermont V, Schlumbohm C, Sewald K, 594 
Autschbach R, Braun A, Kramer BW, Uhlig S, Martin C. Neurally mediated 595 
airway constriction in human and other species: a comparative study using 596 
precision-cut lung slices (PCLS). PLoS One 7: e47344, 2012. 597 
28. Schlepütz M, Uhlig S, Martin C. Electric field stimulation of precision-cut lung 598 
slices. J Appl Physiol (1985) 110:545-54, 2011. 599 
29. Sturton RG, Trifilieff A, Nicholson AG, Barnes PJ. Pharmacological 600 
characterization of indacaterol, a novel once daily inhaled beta-2 adrenoceptor 601 
agonist, on small airways in human and rat precision-cut lung slices. J Pharmacol 602 
Exp Ther 324: 270-275, 2008. 603 
30. Suki B, Bates JH. Extracellular matrix mechanics in lung parenchymal diseases. 604 
Respir Physiol Neurobiol 163: 33-43, 2008. 605 
31. Tjin G, Xu P, Kable SH, Kable EP, Burgess JK. Quantification of collagen I in 606 
airway tissues using second harmonic generation. J Biomed Opt 19: 36005, 607 
2014. 608 
32. Toward TJ, Broadley KJ. Goblet cell hyperplasia, airway function, and leukocyte 609 
infiltration after chronic lipopolysaccharide exposure in conscious guinea pigs: 610 




effects of rolipram and dexamethasone. J Pharmacol Exp Ther 302: 814-821, 611 
2002. 612 
33. Van Dijk EM, Culha S, Menzen MH, Bidan CM, Gosens R. Elastase-induced 613 
parenchymal disruption and airway hyperresponsiveness in mouse precision cut 614 
lung slices: toward an ex vivo COPD model. Front Physiol 7: 657, 2017. 615 
34. Van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman 616 
HF, Timens W, Postma DS. Proteoglycan changes in the extracellular matrix of 617 
lung tissue from patients with pulmonary emphysema. Mod Pathol 12: 697-705, 618 
1999. 619 
35. Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF. Long-620 
term intratracheal lipopolysaccharide exposure in mice results in chronic lung 621 
inflammation and persistent pathology. Am J Respir Cell Mol Biol 26: 152-159, 622 
2002. 623 
36. Zandvoort A, Postma DS, Jonker MR, Noordhoek JA, Vos JT, van der Geld 624 
YM, Timens W. Altered expression of the Smad signalling pathway: implications 625 
for COPD pathogenesis. Eur Respir J 28: 533-541, 2006.  626 






Table 1. Clinical data 629 














Age (years) †  65          
(42-69) 










Ex-/current smoker†  3/1 4/3  
Pack-years†§  40          
(28-52)




FEV1 (% predicted) † 




109.5       
(87-122) 
 
74.2         
(69.4-84.2) 
 
89          
(58-115) 
 





Definition of abbreviations: COPD = chronic obstructive pulmonary disease; FEV1 = forced 631 
expiratory volume in 1 second; FVC = forced vital capacity. 632 
Data except number of subjects, sex and smoking status are expressed as median (range).                           633 
*4 non-COPD patients undergoing surgery for lung cancer and 1 healthy lung donor.  634 
†Data healthy lung donor not available. §Data from 2 control subjects and 2 COPD patients 635 
are missing.  636 




Table 2. Airway responsiveness to methacholine of intrapulmonary large and small airways 637 
in lung slices obtained from saline- and LPS-challenged guinea pigs and of intrapulmonary 638 
small airways in lung slices obtained from control subjects and COPD patients. 639 
Group Large airways Small airways 
 Emax            
(% constriction)
pD2           
(-log M) 
Emax             
(% constriction) 
pD2            
(-log M) 
Guinea pig     
    Saline-challenged    89.7 ± 4.5     5.83 ± 0.12    48.6 ± 5.4†††    5.52 ± 0.25 
    LPS-challenged    98.3 ± 1.0*    6.47 ± 0.17**    72.7 ± 3.9***/†††    5.88 ± 0.26† 
Human     
    Control subjects      45.8 ± 11.1    5.68 ± 0.37 
    COPD patients      67.9 ± 3.2#    5.77 ± 0.18 
Definition of abbreviations: COPD = chronic obstructive pulmonary disease; Emax = maximal 640 
effect; pD2 = -log of the concentration causing 50% effect (-log EC50); LPS = 641 
lipopolysaccharide. Data are presented as means ± SEM of 8-9 guinea pigs per group, 5 642 
control subjects and 7 COPD patients.  643 
*P < 0.05, **P < 0.01 and ***P < 0.001 compared to saline-challenged guinea pigs. †P < 0.05, 644 
†††P < 0.001 compared to corresponding large airways. #P < 0.05 compared to control 645 
subjects.646 




Table 3. Biomechanical parameters fitted to the experimental dose-response curves using 647 
the multiscale biomechanical model of the airway embedded in parenchyma. Note that the 648 










































































































Human        
Control 0.3 5 0.25 1.0 0.4 5 
COPD 0.3 5 0.05 0.14 0.1 100 
Guinea pig       
Small airway - saline 0.27 9 0.2 1.0 0.4 2 
Small airway – LPS (set 1) 0.3 9 0.05 0.09 0.1 100 
Small airway – LPS (set 2) 0.38 9 0.05 0.09 0.1 100 
large airway - saline 0.4 30 0.03 0.1 0.4 10 
 650 
Definition of abbreviations: ASM = airway smooth muscle; COPD = chronic obstructive 651 
pulmonary disease; LPS = lipopolysaccharide.  652 




LEGENDS TO THE FIGURES 653 
 654 
Fig. 1. Airway responsiveness towards methacholine (MCh) of (A) large and (B) small 655 
intrapulmonary airways in lung slices obtained from male guinea pigs challenged with 656 
either saline or LPS, twice weekly for 12 weeks. Data represent means ± SEM of 8-9 657 
animals per group. ***P < 0.001 between curves. 658 
 659 
Fig. 2. (A) α-SMA-positive area of large and small airways in lung slices obtained 660 
from male guinea pigs challenged with either saline or LPS, twice weekly for 12 661 
weeks. Representative pictures are shown for each group and airway classification 662 
(A = airway and V = vessel). The bar indicates 500 μm for the large airways and 200 663 
μm for the small airways. (B) Correlations between airway smooth muscle mass (α-664 
SMA-positive area) and airway responsiveness (pD2, upper panels and Emax, lower 665 
panels) of large and small airways. Data represent means ± SEM of 7-10 animals per 666 
group. ***P < 0.001 compared to large airways. (C) Effects of repeated saline or LPS 667 
challenge on alveolar airspace size (mean linear intercept; MLI) in male guinea pig 668 
lung slices obtained from guinea pigs challenged with either saline or LPS, twice 669 
weekly for 12 weeks. (D) Correlations between MLI and airway responsiveness (pD2, 670 
upper panels and Emax, lower panels) of large and small airways. Data represent 671 
means ± SEM of 8-10 animals per group.  672 
 673 
Fig. 3. Airway responsiveness towards methacholine (MCh) of peripheral airways in 674 
lung slices obtained from control subjects and from patients with COPD. Data 675 
represent means ± SEM of 5 control subjects and 7 COPD patients. **P < 0.01 676 
between curves. 677 
 678 




Fig. 4. (A) α-SMA-positive area in lung slices obtained from control subjects and 679 
COPD patients. Representative pictures are shown for control (top) and COPD 680 
(bottom). Data represent means ± SEM of 5 control subjects and 6 COPD patients. 681 
(B) Alveolar airspace size (mean linear intercept; MLI) in lung slices of control 682 
subjects and COPD patients. Data represent means ± SEM of 5 control subjects and 683 
7 COPD patients. *P < 0.05 compared to control. (C) Correlations between airway 684 
smooth muscle mass (α-SMA-positive area) and airway responsiveness (pD2, upper 685 
panel and Emax, lower panel). (D) Correlations between MLI and airway 686 
responsiveness (pD2, upper panel and Emax, lower panel).  687 
 688 
Fig. 5. (A) Schematic overview of our previously developed multiscale mathematical 689 
model (11) for which a given agonist concentration k1 (model input) causes ASM cell 690 
shortening via acto-myosin cross-bridge interactions at the cell level, thereby 691 
generating airway narrowing at the tissue level. This allows to predict the lumen 692 
radius (r) at each concentration (k1) to generate dose-response curves for a given 693 
set of parameter values for airway and parenchymal mechanical properties and cell 694 
properties listed above. Note that additional outputs are also generated by the model, 695 
such as radial and circumferential tissue stresses (τ) and contractile force at the cell-696 
level (A), but the most direct comparison with experimental data is via the lumen 697 
radius. Multiple simulations were performed in which the parameters were varied 698 
within a range until a dose-response curve (k1 vs r) is generated that best fits the 699 
baseline/control experimental data. Once this fit (a set of baseline parameters) is 700 
obtained, the parameter values are varied one at a time to identify those factors that 701 
contribute the most to the modified dose-response curves of the LPS/COPD data. (B) 702 
Simulated concentration-contraction curves (solid lines) for human control data and 703 
COPD data (from Fig. 3). Inflation pressure for these simulations was set as zero. In 704 




the simulation, the effect of an increased γ, a reduced C1, a reduced C2 and a 705 
reduced v individually as well as the combination of all the parameters were tested 706 
(‘combination’). (C) Simulated dose-response curves (solid lines) for saline- and LPS-707 
treated guinea pig slices for small airways with different wall thickness parameters 708 
(Parameter sets 1 and 2; experimental data from Fig. 1B). (D) Simulated dose-709 
response curves (solid lines) for saline-treated guinea pig slices for large airways 710 
(experimental data from Fig. 1A). Parameter values for the simulated curves are 711 
given in Table 3.   712 
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